Biotech | March 07, 2022
HCmed, Formosa Laboratories, and Formosa Pharmaceuticals form CDMO
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
Patients can use the wearable, non-invasive device to measure six body parameters including blood glucose, blood pressure, heart rate, blood oxygen, respiratory rate and 6-lead ECG, from the comfort of their home
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
This decision does not impact the ongoing AReSVi 006 phase III trial for RSV older adults.
Nirsevimab is the first investigational long-acting antibody designed to protect all infants for the respiratory syncytial virus season with a single dose
Apexxnar is the first pneumococcal conjugate vaccine to help protect adults ages 18 years and older against 20 serotypes responsible for the majority of invasive disease and pneumococcal pneumonia
The entire integration and transition of the brands is expected to be completed by March 2022
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)
Subscribe To Our Newsletter & Stay Updated
